Effect of recombinant human growth hormone on liver fat content in young adults with nonalcoholic fatty liver disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of recombinant human growth hormone on liver fat content in young adults with nonalcoholic fatty liver disease
Authors
Keywords
-
Journal
CLINICAL ENDOCRINOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-10-10
DOI
10.1111/cen.14344
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges
- (2020) Dana Goldner et al. GASTROENTEROLOGY
- Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease
- (2019) Dimitrios A. Koutoukidis et al. JAMA Internal Medicine
- Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2019) Stephen A Harrison et al. LANCET
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial
- (2019) Takara L Stanley et al. Lancet HIV
- NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2018) Stephen A Harrison et al. LANCET
- Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single-centre randomized controlled study
- (2018) Niina Matikainen et al. DIABETES OBESITY & METABOLISM
- Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
- (2018) Arun Sanyal et al. LANCET
- NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children
- (2017) Miriam B. Vos et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy
- (2016) A. Dutour et al. DIABETES OBESITY & METABOLISM
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Resolution of non-alcoholic steatohepatitis after growth hormone replacement in a pediatric liver transplant patient with panhypopituitarism
- (2016) Thomas Gilliland et al. PEDIATRIC TRANSPLANTATION
- Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency
- (2014) Ryusaku Matsumoto et al. GROWTH HORMONE & IGF RESEARCH
- GH-independent IGF-I action is essential to prevent the development of nonalcoholic steatohepatitis in a GH-deficient rat model
- (2012) Hitoshi Nishizawa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy
- (2012) H. Nishizawa et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Metabolic Effects of a Growth Hormone-Releasing Factor in Obese Subjects with Reduced Growth Hormone Secretion: A Randomized Controlled Trial
- (2012) Hideo Makimura et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Increasing Prevalence of Nonalcoholic Fatty Liver Disease Among United States Adolescents, 1988-1994 to 2007-2010
- (2012) Jean A. Welsh et al. JOURNAL OF PEDIATRICS
- Quantification of Liver Fat with Magnetic Resonance Imaging
- (2010) Scott B. Reeder et al. Magnetic Resonance Imaging Clinics of North America
- Liver-specific Deletion of the Growth Hormone Receptor Reveals Essential Role of Growth Hormone Signaling in Hepatic Lipid Metabolism
- (2009) Yong Fan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effect of Body Mass Index on Peak Growth Hormone Response to Provocative Testing in Children with Short Stature
- (2009) Takara L. Stanley et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls
- (2008) Madhusmita Misra et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The Effects of Central Adiposity on Growth Hormone (GH) Response to GH-Releasing Hormone-Arginine Stimulation Testing in Men
- (2008) Hideo Makimura et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Changing Patterns of the Adult Growth Hormone Deficiency Diagnosis Documented in a Decade-Long Global Surveillance Database
- (2008) Susan M. Webb et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started